ClinicalTrials.Veeva

Menu

Adipokines of Epicardial Adipose Tissue and Atherosclerosis of Coronary Arteries

U

University Hospital, Ioannina

Status

Unknown

Conditions

Coronary Atherosclerosis
Adipokines

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The aim of the study is to investigate whether the expression and production of adipokines secreted by the epicardial adipose tissue correlate with the degree of coronary atherosclerosis.

Full description

The aim of the study is to investigate whether the expression and production of four adipokines [adiponectin, omenin-1, resistin and retinol binding protein-4 (RBP4)] secreted by the epicardial adipose tissue correlate with the degree of coronary atherosclerosis. Specifically, this study aims to investigate whether the expression and production of these adipokines is different between two sites of the heart, that are perfused by coronary arteries with different degrees of stenosis.

Enrollment

160 estimated patients

Sex

Male

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Individuals undergoing cardiac surgery

Exclusion criteria

  • Age < 18 years
  • HbA1c > 7.0%
  • Any change of antidiabetic medication the previous 3 months before the surgery
  • GFR < 60 mL/min/1.73 m2
  • Liver disease
  • Cancer
  • Non-treated hyperthyroidism or hypothyroidism
  • Autoimmune disease
  • Infection
  • Any change in body weight at least 5% the previous 3 months before surgery
  • Significant dehydration.
  • Taking any of the following drugs the previous 3 months before surgery: hormones, antiobesity drugs

Trial design

160 participants in 8 patient groups

NonDM-0
Description:
Nondiabetics without significant stenoses (\> 50%) in the coronary arteries
NonDM-L
Description:
Nondiabetics with significant stenosis in the left anterior descending (LAD) coronary artery or in the Left main (LM) coronary artery, but without significant stenosis in the right coronary artery (RCA)
NonDM-R
Description:
Nondiabetics without significant stenosis in the LAD and in the LM, but with significant stenosis in the RCA
NonDM-LR
Description:
Nondiabetics with significant stenosis in the LAD or in the LM and with significant stenosis in the RCA
DM-0
Description:
Patients with type 2 diabetes mellitus (T2DM) without significant stenoses in the coronary arteries
DM-L
Description:
T2DM patients with significant stenosis in the LAD or in the LM, but without significant stenosis in RCA
DM-R
Description:
T2DM patients without significant stenosis in the LAD and in the LM, but with significant stenosis in the RCA
DM-LR
Description:
T2DM patients with significant stenosis in the LAD or in the LM and with significant stenosis in the RCA

Trial contacts and locations

1

Loading...

Central trial contact

Eustratios Apostolakis, Professor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems